Januar 2014 - IOZK

Postoperative dendritic cell vaccine plus activated T-cell transfer improves the survival of patients with invasive hepatocellular carcinoma

2014-01-13/in Dendritic Cells, Hepatocellular Carcinoma, International Publications

Two is better than one: Complementing oncolytic virotherapy with gemcitabine to potentiate antitumor immune responses

2014-01-06/in International Publications, Newcastle Disease Virus

Different responses of human pancreatic adenocarcinoma cell lines to oncolytic Newcastle disease virus infection

2014-01-03/in International Publications, Newcastle Disease Virus, Pancreatic Cancer

Concomitant gemcitabine therapy negatively affects DC vaccine-induced CD8(+) T-cell and B-cell responses but improves clinical efficacy in a murine pancreatic carcinoma model

2014-01-03/in Dendritic Cells, International Publications

Dendritic cell immunotherapy in uterine cancer

2014-01-01/in Dendritic Cells, Endometrial Cancer, International Publications

Novel dendritic cell-based vaccination in late stage melanoma

2014-01-01/in Dendritic Cells, International Publications, Malignant Melanoma

Dendritic cell-based vaccines: clinical applications in breast cancer

2014-01-01/in Breast Cancer, Dendritic Cells, International Publications

Autologous tumor cell vaccines for post-operative active-specific immunotherapy of colorectal carcinoma: long-term patient survival and mechanism of function

2014-01-01/in Colorectal Cancer, Dendritic Cells, International Publications, IOZK Veröffentlichungen

Immunotherapy and lung cancer: current developments and novel targeted therapies

2014-01-01/in Dendritic Cells, International Publications, NSCLC

Generation of multiple peptide cocktail-pulsed dendritic cells as a cancer vaccine

2014-01-01/in Dendritic Cells, International Publications